Thank you, Madam Chair.
My question is for Mr. Glover.
As you probably heard, Dr. Lexchin recommended that Health Canada create an expert committee to identify off-patent drugs that are supplied by only one or two companies and that are considered “critical” to medical care. I won't list all of his recommendations, which also call for Health Canada to identify alternative sources of drugs deemed critical to the health of Canadians.
I would like you to comment on his suggestion of convening an expert committee that would be tasked with identifying alternative drug sources.